# Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer

> **NCT03381352** · PHASE2 · UNKNOWN · sponsor: **Chinese Academy of Medical Sciences** · enrollment: 27 (estimated)

## Conditions studied

- Anal Cancer

## Interventions

- **RADIATION:** Chemo-radiotherapy with IMRT technique
- **DRUG:** Capecitabine
- **DRUG:** Mitomycin C

## Key facts

- **NCT ID:** NCT03381352
- **Lead sponsor:** Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12-02
- **Primary completion:** 2018-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03381352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03381352, "Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03381352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*